CAN FOOD AFFECT THE BIOAVAILABILITY OF CHLORAMBUCIL IN PATIENTS WITH HEMATOLOGICAL MALIGNANCIES

被引：22
作者：
ADAIR, CG
BRIDGES, JM
DESAI, ZR
机构：
来源：
CANCER CHEMOTHERAPY AND PHARMACOLOGY | 1986年 / 17卷 / 01期
关键词：
D O I：
10.1007/BF00299876
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
引用
收藏
页码：99 / 102
页数：4
相关论文
共 15 条
[1]   DETERMINATION OF CHLORAMBUCIL IN PLASMA USING REVERSED-PHASE HIGH-PERFORMANCE LIQUID-CHROMATOGRAPHY [J].
ADAIR, CG ;
BURNS, DT ;
CROCKARD, AD ;
HARRIOTT, M .
JOURNAL OF CHROMATOGRAPHY, 1985, 342 (02) :447-451
[2]  
ALBERTS DS, 1980, RECENT RES CANCER, V74, P124
[3]  
BACHRACH W H, 1959, Clin Symp, V11, P3
[4]  
BOSANQUET AG, 1984, CANCER CHEMOTH PHARM, V12, P183
[5]   KINETICS OF CHLORAMBUCIL HYDROLYSIS USING HIGH-PRESSURE LIQUID-CHROMATOGRAPHY [J].
CHATTERJI, DC ;
YEAGER, RL ;
GALLELLI, JF .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1982, 71 (01) :50-54
[6]   PREDICTION OF CREATININE CLEARANCE FROM SERUM CREATININE [J].
COCKCROFT, DW ;
GAULT, MH .
NEPHRON, 1976, 16 (01) :31-41
[7]  
CORNWELL GG, 1982, CANCER TREAT REP, V66, P475
[8]   EFFECT OF FOOD ON PHARMACOKINETICS OF CHLORAMBUCIL AND ITS MAIN METABOLITE, PHENYLACETIC ACID MUSTARD [J].
EHRSSON, H ;
WALLIN, I ;
SIMONSSON, B ;
HARTVIG, P ;
OBERG, G .
EUROPEAN JOURNAL OF CLINICAL PHARMACOLOGY, 1984, 27 (01) :111-114
[9]   TREATMENT OF CHRONIC LYMPHOCYTIC-LEUKEMIA AND WELL-DIFFERENTIATED LYMPHOCYTIC LYMPHOMA WITH CONTINUOUS LOW-DOSE OR INTERMITTENT HIGH-DOSE PREDNIMUSTINE VERSUS CHLORAMBUCIL PREDNISOLONE [J].
IDESTROM, K ;
KIMBY, E ;
BJORKHOLM, M ;
MELLSTEDT, H ;
ENGSTEDT, L ;
GAHRTON, G ;
JOHANSSON, B ;
KILLANDER, D ;
ROBERTS, KH ;
STALFELT, AM ;
UDEN, AM ;
WADMAN, B ;
WAHLBY, S .
EUROPEAN JOURNAL OF CANCER & CLINICAL ONCOLOGY, 1982, 18 (11) :1117-1123
[10]   EFFECT OF VISCOSITY ON DRUG ABOSRPTION [J].
LEVY, G ;
JUSKO, WJ .
JOURNAL OF PHARMACEUTICAL SCIENCES, 1965, 54 (02) :219-+
12